LivaNova announced the launch and enrollment of the first patient in the study to Assess Effectiveness and Efficiency of Vagus Nerve Stimulation Therapy® as Adjunctive Therapy in Patients with Difficult to Treat Depression.
LivaNova announced the launch and enrollment of the first patient in the study to Assess Effectiveness and Efficiency of Vagus Nerve Stimulation Therapy® as Adjunctive Therapy in Patients with Difficult to Treat Depression.